Effect of tumor necrosis factor-α on intracellular Staphylococcus aureus in vascular endothelial cells

FEMS Immunology and Medical Microbiology

Volumn 52, Issue 2, 2008, Pages 247-252

  Park, Wan Beom ^a   Lee, Jae Hoon ^a   Jeon, Jae Hyun ^a   Lee, Su Jin ^a   Kim, Sung Han ^a   Kim, Nam Joong ^a   Kim, Hong Bin ^a   Oh, Myoung Don ^a   Choe, Kang Won ^a  

^a Seoul National University   (South Korea)

Author keywords

Apoptosis; Staphylococcus aureus; Tumor necrosis factor

Indexed keywords

ANTIBIOTIC AGENT; LACTATE DEHYDROGENASE; OXACILLIN; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; INTERNALIZATION; NONHUMAN; PHOTOMETRY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STAPHYLOCOCCUS AUREUS; SURVIVAL; VASCULAR ENDOTHELIUM;

ANTI-BACTERIAL AGENTS; APOPTOSIS; CELL LINE; COLONY COUNT, MICROBIAL; ENDOTHELIAL CELLS; HUMANS; L-LACTATE DEHYDROGENASE; MICROBIAL VIABILITY; OXACILLIN; STAPHYLOCOCCUS AUREUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 39049127039     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2007.00365.x     Document Type: Article

References (26)

1. Ashkenazi A Dixit VM (1998) Death receptors: signaling and modulation. Science 281 : 1305 1308.
2. Bermudez LE Young LS (1988) Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. J Immunol 140 : 3006 3013.
3. Board of the ASHSP (1999) AHFS Drug Information. American Society of Health-System Pharmacists Inc, Bethesda, MD.
4. Bonifacio JS (2000) Current Protocols in Cell Biology. John Wiley & Sons Inc, New York.
5. Darouiche RO Hamill RJ (1994) Antibiotic penetration of and bactericidal activity within endothelial cells. Antimicrob Agents Chemother 38 : 1059 1064.
6. De Assis MC, Da Costa AO, Barja-Fidalgo TC Plotkowski MC (2000) Human endothelial cells are activated by interferon-gamma plus tumour necrosis factor-alpha to kill intracellular Pseudomonas aeruginosa. Immunology 101 : 271 278.
7. Decker T Lohmann-Matthes ML (1988) A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 115 : 61 69.
8. Easmon CS, Lanyon H Cole PJ (1978) Use of lysostaphin to remove cell-adherent staphylococci during in vitro assays of phagocyte function. Br J Exp Pathol 59 : 381 385.
9. Esen M, Schreiner B, Jendrossek V, Lang F, Fassbender K, Grassme H Gulbins E (2001) Mechanisms of Staphylococcus aureus induced apoptosis of human endothelial cells. Apoptosis 6 : 431 439.
10. Friedland JS, Porter JC, Daryanani S, Bland JM, Screaton NJ, Vesely MJ, Griffin GE, Bennett ED Remick DG (1996) Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) III scores and survival in patients in an intensive care unit. Crit Care Med 24 : 1775 1781.
11. Haslinger-Loffler B, Kahl BC, Grundmeier M, Strangfeld K, Wagner B, Fischer U, Cheung AL, Peters G, Schulze-Osthoff K Sinha B (2005) Multiple virulence factors are required for Staphylococcus aureus-induced apoptosis in endothelial cells. Cell Microbiol 7 : 1087 1097.
12. Khosrovaneh A, Riederer K, Saeed S, Tabriz MS, Shah AR, Hanna MM, Sharma M, Johnson LB, Fakih MG Khatib R (2004) Frequency of reduced vancomycin susceptibility and heterogeneous subpopulation in persistent or recurrent methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 38 : 1328 1330.
13. Kindler V, Sappino AP, Grau GE, Piguet PF Vassalli P (1989) The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56 : 731 740.
14. Krut O, Sommer H Kronke M (2004) Antibiotic-induced persistence of cytotoxic Staphylococcus aureus in non-phagocytic cells. J Antimicrob Chemother 53 : 167 173.
15. Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339 : 520 532.
16. Menzies BE Kourteva I (1998) Internalization of Staphylococcus aureus by endothelial cells induces apoptosis. Infect Immun 66 : 5994 5998.
17. Mor A, Mitnick HJ, Greene JB, Azar N, Budnah R Fetto J (2006) Relapsing oligoarticular septic arthritis during etanercept treatment of rheumatoid arthritis. J Clin Rheumatol 12 : 87 89.
18. Ogawa SK, Yurberg ER, Hatcher VB, Levitt MA Lowy FD (1985) Bacterial adherence to human endothelial cells in vitro. Infect Immun 50 : 218 224.
19. Pascual A, Ballesta S, Garcia I Perea EJ (2002) Uptake and intracellular activity of linezolid in human phagocytes and nonphagocytic cells. Antimicrob Agents Chemother 46 : 4013 4015.
20. Pohlman TH Harlan JM (1989) Human endothelial cell response to lipopolysaccharide, interleukin-1, and tumor necrosis factor is regulated by protein synthesis. Cell Immunol 119 : 41 52.
21. Sato N, Goto T, Haranaka K, Satomi N, Nariuchi H, Mano-Hirano Y Sawasaki Y (1986) Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity. J Natl Cancer Inst 76 : 1113 1121.
22. Schwab JC Mandell GL (1989) The importance of penetration of antimicrobial agents into cells. Infect Dis Clin North Am 3 : 461 467.
23. Schwarz-Linek U, Werner JM, Pickford AR et al 2003) Pathogenic bacteria attach to human fibronectin through a tandem beta-zipper. Nature 423 : 177 181.
24. Siegman-Igra Y, Reich P, Orni-Wasserlauf R, Schwartz D Giladi M (2005) The role of vancomycin in the persistence or recurrence of Staphylococcus aureus bacteraemia. Scand J Infect Dis 37 : 572 578.
25. Sinha B, Francois PP, Nusse O, Foti M, Hartford OM, Vaudaux P, Foster TJ, Lew DP, Herrmann M Krause KH (1999) Fibronectin-binding protein acts as Staphylococcus aureus invasin via fibronectin bridging to integrin alpha5beta1. Cell Microbiol 1 : 101 117.
26. Van Belkum A, Kools-Sijmons M Verbrugh H (2002) Attachment of Staphylococcus aureus to eukaryotic cells and experimental pitfalls in staphylococcal adherence assays: a critical appraisal. J Microbiol Methods 48 : 19 42.